Knowledge Library Prototype
Psychiatry Intelligence
Prototype collection covering depression, anxiety, bipolar disorder, schizophrenia, substance use disorders, psychopharmacology, digital mental health, FDA updates, clinical trials, and AJPPS research.
Featured AJPPS Research
Placeholder for AJPPS mental health and psychopharmacology articles.
Latest Psychiatry Intelligence
Reserved for approved RSS/API content.
FDA & Regulatory Updates
- CDER Manual of Policies & Procedures | MAPP
by FDA on 07/16/2026 at 2:46 pmCDER's Manual of Policies and Procedures (MAPPs) are federal directives and documentation of internal policies and procedures.
- Recently Issued Guidance Documentsby FDA on 07/16/2026 at 12:51 pm
This page lists Recently Issued CBER and Cross-Center Guidance Documents.
- What's New Related to Drugsby FDA on 07/16/2026 at 12:00 pm
Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.
- Notable Approvals | Drugsby FDA on 07/16/2026 at 11:54 am
News about human drug-related approvals
- FDA Approves First Oral Therapy that Inhibits Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) to Lower Bad Cholesterol in Adults with High Cholesterolby FDA on 07/16/2026 at 11:54 am
FDA has approved Lipfendra (enlicitide) as a treatment to be used with diet and exercise, to reduce low-density lipoprotein cholesterol (LDL-C) in adults with high cholesterol or who have an inherited type of high cholesterol called heterozygous familial hypercholesterolemia (HeFH).
Clinical Trials Watch
Future ClinicalTrials.gov integration for psychiatric disorders.
Clinical Practice & Therapeutics
Future guideline summaries, safety updates, and patient-centered pharmacy care resources.
Related Collections
- Neurology Intelligence
- Pharmacogenomics Intelligence
- FDA Approvals & Medication Safety